New drug aims to tame dangerous fat levels in blood

NCT ID NCT05852431

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a drug called pegozafermin in 369 adults with severe hypertriglyceridemia, a condition where blood fat levels are dangerously high. Participants received either the drug or a placebo for 26 weeks. The main goal was to see if the drug could safely lower triglyceride levels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

pegozafermin

What this could lead to

If it works, this could provide a new treatment option to lower dangerously high triglycerides and reduce the risk of pancreatitis and heart disease.

What could go wrong

This is a completed Phase 3 trial, but results are not yet public. The drug may not work better than placebo, and side effects are possible with any new medication.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE HYPERTRIGLYCERIDEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Dyslipidemias hyperlipidemia hypertriglyceridemia Lipid Metabolism Disorders metabolic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • 89 Clinical Study Site

    Austin, Texas, 78757, United States

  • 89Bio Clinical Study Site

    Tucson, Arizona, 85712, United States

  • 89Bio Clinical Study Site

    Long Beach, California, 90815, United States

  • 89Bio Clinical Study Site

    Tustin, California, 92780, United States

  • 89Bio Clinical Study Site

    Clearwater, Florida, 33756, United States

  • 89Bio Clinical Study Site

    Homestead, Florida, 33030, United States

  • 89Bio Clinical Study Site

    Miami Lakes, Florida, 33014, United States

  • 89Bio Clinical Study Site

    Orlando, Florida, 32825, United States

  • 89Bio Clinical Study Site

    Tampa, Florida, 33606, United States

  • 89Bio Clinical Study Site

    Columbus, Georgia, 31904, United States

  • 89Bio Clinical Study Site

    Lawrenceville, Georgia, 30044, United States

  • 89Bio Clinical Study Site

    Chicago, Illinois, 60607, United States

  • 89Bio Clinical Study Site

    Wichita, Kansas, 67205, United States

  • 89Bio Clinical Study Site

    Marrero, Louisiana, 70072, United States

  • 89Bio Clinical Study Site

    Oxon Hill, Maryland, 20745, United States

  • 89Bio Clinical Study Site

    North Massapequa, New York, 11758, United States

  • 89Bio Clinical Study Site

    Morganton, North Carolina, 28655, United States

  • 89Bio Clinical Study Site

    Eugene, Oregon, 97404, United States

  • 89Bio Clinical Study Site

    Chattanooga, Tennessee, 37421, United States

  • 89Bio Clinical Study Site

    Lampasas, Texas, 76550, United States

  • 89Bio Clinical Study Site

    Burke, Virginia, 22015, United States

  • 89Bio Clinical Study Site

    San Juan, 00927, Puerto Rico

  • 89bio Clincal Study Site

    London, N128BU, United Kingdom

  • 89bio Clinical Study Site

    Chandler, Arizona, 85712, United States

  • 89bio Clinical Study Site

    Peoria, Arizona, 85381, United States

  • 89bio Clinical Study Site

    Conway, Arkansas, 72032, United States

  • 89bio Clinical Study Site

    Jonesboro, Arkansas, 72401, United States

  • 89bio Clinical Study Site

    Little Rock, Arkansas, 72205, United States

  • 89bio Clinical Study Site

    Los Angeles, California, 90057, United States

  • 89bio Clinical Study Site

    Santa Ana, California, 92705, United States

  • 89bio Clinical Study Site

    Thousand Oaks, California, 91360, United States

  • 89bio Clinical Study Site

    Wheat Ridge, Colorado, 80033, United States

  • 89bio Clinical Study Site

    Bridgeport, Connecticut, 06610, United States

  • 89bio Clinical Study Site

    Clearwater, Florida, 33761, United States

  • 89bio Clinical Study Site

    Hialeah Gardens, Florida, 33016, United States

  • 89bio Clinical Study Site

    Miramar, Florida, 33027, United States

  • 89bio Clinical Study Site

    Panama City, Florida, 32401, United States

  • 89bio Clinical Study Site

    Atlanta, Georgia, 30309, United States

  • 89bio Clinical Study Site

    West Des Moines, Iowa, 50265, United States

  • 89bio Clinical Study Site

    Flint, Michigan, 48504, United States

  • 89bio Clinical Study Site

    St Louis, Missouri, 63110, United States

  • 89bio Clinical Study Site

    Las Vegas, Nevada, 89106, United States

  • 89bio Clinical Study Site

    Las Vegas, Nevada, 89118, United States

  • 89bio Clinical Study Site

    East Syracuse, New York, 13057, United States

  • 89bio Clinical Study Site

    Cincinnati, Ohio, 45227, United States

  • 89bio Clinical Study Site

    Middleburg Heights, Ohio, 44130, United States

  • 89bio Clinical Study Site

    Stow, Ohio, 44224, United States

  • 89bio Clinical Study Site

    Oklahoma City, Oklahoma, 73102, United States

  • 89bio Clinical Study Site

    Charleston, South Carolina, 29414, United States

  • 89bio Clinical Study Site

    Tullahoma, Tennessee, 37388, United States

  • 89bio Clinical Study Site

    Amarillo, Texas, 79106, United States

  • 89bio Clinical Study Site

    Dallas, Texas, 75226, United States

  • 89bio Clinical Study Site

    Graham, Texas, 76450, United States

  • 89bio Clinical Study Site

    Houston, Texas, 77030, United States

  • 89bio Clinical Study Site

    Mansfield, Texas, 76063, United States

  • 89bio Clinical Study Site

    San Antonio, Texas, 78209, United States

  • 89bio Clinical Study Site

    Wichita Falls, Texas, 76301, United States

  • 89bio Clinical Study Site

    Rosario, Santa Fe Province, 2000, Argentina

  • 89bio Clinical Study Site

    Buenos Aires, C1023AAB, Argentina

  • 89bio Clinical Study Site

    Buenos Aires, C1425CABA, Argentina

  • 89bio Clinical Study Site

    Buenos Aires, C1426ABP, Argentina

  • 89bio Clinical Study Site

    Córdoba, 5000, Argentina

  • 89bio Clinical Study Site

    Córdoba, 5749, Argentina

  • 89bio Clinical Study Site

    Córdoba, X5000 BSQ, Argentina

  • 89bio Clinical Study Site

    Córdoba, X5000AAX, Argentina

  • 89bio Clinical Study Site

    Córdoba, X5004CDT, Argentina

  • 89bio Clinical Study Site

    Mendoza, M5509, Argentina

  • 89bio Clinical Study Site

    Rosario, S2000CVD, Argentina

  • 89bio Clinical Study Site

    San Miguel de Tucumán, T400IHE, Argentina

  • 89bio Clinical Study Site

    Viedma, R8500ACE, Argentina

  • 89bio Clinical Study Site

    Graz, A-8036, Austria

  • 89bio Clinical Study Site

    Edegem, 2650, Belgium

  • 89bio Clinical Study Site

    Ghent, 9000, Belgium

  • 89bio Clinical Study Site

    Haine-Saint-Paul, 7100, Belgium

  • 89bio Clinical Study Site

    Yvoir, 5530, Belgium

  • 89bio Clinical Study Site

    Dimitrovgrad, 6400, Bulgaria

  • 89bio Clinical Study Site

    Sliven, 8800, Bulgaria

  • 89bio Clinical Study Site

    Sofia, 1336, Bulgaria

  • 89bio Clinical Study Site

    Sofia, 1431, Bulgaria

  • 89bio Clinical Study Site

    Sofia, 1606, Bulgaria

  • 89bio Clinical Study Site

    Sofia, 1618, Bulgaria

  • 89bio Clinical Study Site

    Veliko Tarnovo, 5000, Bulgaria

  • 89bio Clinical Study Site

    North Vancouver, British Columbia, V7M 2H4, Canada

  • 89bio Clinical Study Site

    Brampton, Ontario, L6R3J7, Canada

  • 89bio Clinical Study Site

    Chicoutimi, Quebec, G7H 7K9, Canada

  • 89bio Clinical Study Site

    Laval, Quebec, H7T2P5, Canada

  • 89bio Clinical Study Site

    Montreal, Quebec, H2W1R7, Canada

  • 89bio Clinical Study Site

    Québec, Quebec, G1V 4G5, Canada

  • 89bio Clinical Study Site

    Concepción, 4030000, Chile

  • 89bio Clinical Study Site

    Santiago, 8330336, Chile

  • 89bio Clinical Study Site

    Santiago, 8910259, Chile

  • 89bio Clinical Study Site

    Valdivia, 5090000, Chile

  • 89bio Clinical Study Site

    Viña del Mar, 2520997, Chile

  • 89bio Clinical Study Site

    Brno, 60200, Czechia

  • 89bio Clinical Study Site

    Brno, 65691, Czechia

  • 89bio Clinical Study Site

    Prague, 12808, Czechia

  • 89bio Clinical Study Site

    Prague, 14021, Czechia

  • 89bio Clinical Study Site

    Prague, 15006, Czechia

  • 89bio Clinical Study Site

    Marseille, 13005, France

  • 89bio Clinical Study Site

    Paris, 75013, France

  • 89bio Clinical Study Site

    Valenciennes, 59300, France

  • 89bio Clinical Study Site

    Batumi, 6000, Georgia

  • 89bio Clinical Study Site

    Tbilisi, 0160, Georgia

  • 89bio Clinical Study Site

    Tbilisi, 0177, Georgia

  • 89bio Clinical Study Site

    Tbilisi, 0186, Georgia

  • 89bio Clinical Study Site

    Essen, 45147, Germany

  • 89bio Clinical Study Site

    Leipzig, 27 04103, Germany

  • 89bio Clinical Study Site

    Baja, Hungary

  • 89bio Clinical Study Site

    Nyíregyháza, 4400, Hungary

  • 89bio Clinical Study Site

    Belagāve, 590010, India

  • 89bio Clinical Study Site

    Bīkaner, 334001, India

  • 89bio Clinical Study Site

    Dehradun, 248001, India

  • 89bio Clinical Study Site

    Jaipur, 302017, India

  • 89bio Clinical Study Site

    Nagpur, 441108, India

  • 89bio Clinical Study Site

    Pimpri-Chinchwad, 411057, India

  • 89bio Clinical Study Site

    Varanasi, 221010, India

  • 89bio Clinical Study Site

    Milan, 20138, Italy

  • 89bio Clinical Study Site

    Modena, 41126, Italy

  • 89bio Clinical Study Site

    Reggio Emilia, 42123, Italy

  • 89bio Clinical Study Site

    Daugavpils, Latvia

  • 89bio Clinical Study Site

    Zemgale, 1002, Latvia

  • 89bio Clinical Study Site

    Monterrey, Nuevo León, 64310, Mexico

  • 89bio Clinical Study Site

    Cuernavaca, Mexico

  • 89bio Clinical Study Site

    General Escobedo, 66050, Mexico

  • 89bio Clinical Study Site

    Guadalajara, 76100, Mexico

  • 89bio Clinical Study Site

    Querétaro City, 76100, Mexico

  • 89bio Clinical Study Site

    Tlalpan, 14080, Mexico

  • 89bio Clinical Study Site

    Bialystok, 15-351, Poland

  • 89bio Clinical Study Site

    Krakow, 30-348, Poland

  • 89bio Clinical Study Site

    Krakow, 31-501, Poland

  • 89bio Clinical Study Site

    Lodz, 91-363, Poland

  • 89bio Clinical Study Site

    Lodz, 93-338, Poland

  • 89bio Clinical Study Site

    Lublin, 20-362, Poland

  • 89bio Clinical Study Site

    Warsaw, 00-215, Poland

  • 89bio Clinical Study Site

    Barcelona, 08036, Spain

  • 89bio Clinical Study Site

    Barcelona, 08041, Spain

  • 89bio Clinical Study Site

    Barcelona, 08907, Spain

  • 89bio Clinical Study Site

    Cadiz, 11009, Spain

  • 89bio Clinical Study Site

    Córdoba, 14004, Spain

  • 89bio Clinical Study Site

    Granada, 18014, Spain

  • 89bio Clinical Study Site

    Granada, 18016, Spain

  • 89bio Clinical Study Site

    Huelva, 21005, Spain

  • 89bio Clinical Study Site

    Madrid, 28041, Spain

  • 89bio Clinical Study Site

    Málaga, 29004, Spain

  • 89bio Clinical Study Site

    Pamplona, 31008, Spain

  • 89bio Clinical Study Site

    Cardiff, CF14 4XW, United Kingdom

  • 89bio Clinical Study Sites

    Sparta, New Jersey, 07871, United States

  • 89bio Clinical Trial Site

    Huntington Park, California, 90255, United States

  • 89bio Clinical Trial Site

    Northridge, California, 91325, United States

  • 89bio Clinical Trial Site

    Panorama City, California, 91402, United States

  • 89bio Clinical Trial Site

    Santa Ana, California, 92705, United States

  • 89bio Clinical Trial Site

    Wheat Ridge, Colorado, 80033, United States

  • 89bio Clinical Trial Site

    Port Orange, Florida, 32127, United States

  • 89bio Clinical Trial Site

    Shreveport, Louisiana, 71105, United States

  • 89bio Clinical Trial Site

    Kansas City, Missouri, 64131, United States

  • 89bio Clinical Trial Site

    New Windsor, New York, 12553, United States

  • 89bio Clinical Trial Site

    New York, New York, 10029, United States

  • 89bio Clinical Trial Site

    Richmond Hill, New York, 77379, United States

  • 89bio Clinical Trial Site

    Syracuse, New York, 13057, United States

  • 89bio Clinical Trial Site

    Columbus, Ohio, 43213, United States

  • 89bio Clinical Trial Site

    Clarksville, Tennessee, 37040, United States

  • 89bio Clinical Trial Site

    San Antonio, Texas, 78207, United States

  • 89bio Clinical Trial Site

    Salt Lake City, Utah, 84107, United States

  • 89bio Clinical Trial Site

    Richmond, Virginia, 23249, United States

  • 89bio Clinical Trial Site

    Vienna, 1030, Austria

  • 89bio Clinical Trial Site

    Vienna, 1130, Austria

  • 89bio Clinical Trial Site

    Botevgrad, 2140, Bulgaria

  • 89bio Clinical Trial Site

    Plovdiv, 4004, Bulgaria

  • 89bio Clinical Trial Site

    Sliven, 8800, Bulgaria

  • 89bio Clinical Trial Site

    Sofia, 1202, Bulgaria

  • 89bio Clinical Trial Site

    Veliko Tarnovo, 5000, Bulgaria

  • 89bio Clinical Trial Site

    Kutaisi, 4600, Georgia

  • 89bio Clinical Trial Site

    Tbilisi, 0159, Georgia

  • 89bio Clinical Trial Site

    Balatonfüred, 8230, Hungary

  • 89bio Clinical Trial Site

    Budapest, 1122, Hungary

  • 89bio Clinical Trial Site

    Riga, 1002, Latvia

  • 89bio Cllinical Study Site

    Genova, 16132, Italy